All In Biotech

Drugs by condition

Drugs approved for blood clots (dvt and pulmonary embolism)

Brand-name prescription drugs and biologics whose FDA label lists blood clots (dvt and pulmonary embolism) as an approved use. Matched on the label phrases: "deep vein thrombosis", "pulmonary embolism".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

19

Still marketed, NDA or BLA

Drug classes

3

Novel drugs

8

New molecular entities and new biologics

In development

4

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for blood clots (dvt and pulmonary embolism).

  • Eliquis (Apixaban) · Bristol Priority reviewApr 17, 2025
  • Technegas Kit (Technetium Tc-99m Labeled Carbon) · Cyclomedica Sep 29, 2023
  • Savaysa (Edoxaban Tosylate) · Daiichi Sankyo INC NovelJan 8, 2015
  • Eliquis (Apixaban) · Bristol Myers Squibb NovelPriority reviewOrphanDec 28, 2012
  • Heparin Sodium (Heparin Sodium) · Pfizer Jul 21, 2011

All approved drugs for blood clots (dvt and pulmonary embolism), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 53 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Factor Xa Inhibitor (3)

  • Eliquis Apixaban · Bristol Myers Squibb · 2012
  • Xarelto Rivaroxaban · Janssen Pharms · 2011
  • Eliquis Apixaban · Bristol · 2025

Lead Chelator (1)

Class not listed in FDA's data (15)

Drugs in development for blood clots (dvt and pulmonary embolism)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • Supergene, LLC · Pulmonary Embolism

  • TS23Phase 22 trials

    Translational Sciences, Inc. · Ischemic Stroke, Pulmonary Embolism

  • VortosiranPhase 22 trials

    Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)

  • BAY3018250Phase 21 trial

    Bayer · Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis

1 discontinued brand-name drugs whose label still names it

More on blood clots (dvt and pulmonary embolism): recruiting trials · published research

Related in cardiovascular and metabolic: Type 2 diabetes · Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Atrial fibrillation · Stroke prevention · Coronary artery disease and heart attack

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.